TRex Bio Inc.
Support and Resistance Levels
Past performance
News About TRXB
All events for TRXB
All deals for TRXB
Financial Ratios
Financial Statements
TRXB vs Sector & Peers
About TRex Bio Inc.
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA. Website trex.bio
Headquarters South San Francisco, CA, US